Literature DB >> 18165810

Renoprotection with vitamin D: specific for diabetic nephropathy?

G Klaus1.   

Abstract

Zhang and co-workers report on the renoprotective role of the vitamin D receptor (VDR) in diabetic nephropathy using the method of streptozotocin-induced hyperglycemia in wild-type and VDR(-/-) mice. Also, experiments with cultured mesangial cells and podocytes confirm the effect of the active vitamin D metabolite 1,25(OH)(2)D(3) on inhibition of the renin-angiotensin system (RAS) in vitro. The authors conclude that the higher activation of the intrarenal RAS is the key factor to induce more severe diabetic nephropathy in VDR(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18165810     DOI: 10.1038/sj.ki.5002693

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

2.  Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism.

Authors:  Xiaoxin X Wang; Tao Jiang; Yan Shen; Hannah Santamaria; Nathaniel Solis; Cynthia Arbeeny; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

Review 3.  The virtues of vitamin D--but how much is too much?

Authors:  Rukshana Shroff; Craig Knott; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2010-09       Impact factor: 3.714

4.  Calcitriol Treatment Attenuates Uric Acid-Induced Kidney Injury via Super Oxide Dismutase-1 (SOD-1) Upregulation and Fibrosis Reduction

Authors:  Muhammad Mansyur Romi; Nur Arefian; Wiwit Ananda Wahyu Setyaningsih; Rachma Greta Perdana Putri; Mohammad Juffrie; Dwi Cahyani Ratna Sari
Journal:  Iran Biomed J       Date:  2021-11-01

5.  Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.

Authors:  Zhongyi Zhang; Yan Zhang; Gang Ning; Dilip K Deb; Juan Kong; Yan Chun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-06       Impact factor: 11.205

6.  SERUM 25-HYDROXYVITAMIN D(3) LEVELS IN TYPE 2 DIABETIC PATIENTS WITH NORMO-, MICRO-, AND MACROALBUMINURIA.

Authors:  F Sari; S Ozdem; R Sari
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

7.  Nuclear hormone receptors in podocytes.

Authors:  Simran Khurana; Leslie A Bruggeman; Hung-Ying Kao
Journal:  Cell Biosci       Date:  2012-09-20       Impact factor: 7.133

8.  The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  NDT Plus       Date:  2009-03-24

9.  Analysis of the associations between vitamin D and albuminuria or β-cell function in Chinese type 2 diabetes.

Authors:  Xiaoling Cai; Zhaoheng Hu; Ling Chen; Xueyao Han; Linong Ji
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

10.  CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation.

Authors:  Alexandre Tourigny; Frédrick Charbonneau; Paul Xing; Rania Boukrab; Guy Rousseau; René St-Arnaud; Marie-Luise Brezniceanu
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.